{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:13:35Z","timestamp":1791288815526,"version":"4.3.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lfs.2026.124578","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:52:43Z","timestamp":1783439563000},"page":"124578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"402","author":[{"given":"Ayman Ali Mohammed","family":"Alameen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124578_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124578_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194582","article-title":"The clinical and neuropathological features of sporadic (late-onset) and genetic forms of Alzheimer\u2019s disease","volume":"10","author":"Rujeedawa","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2026.124578_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.lfs.2026.124578_bb0020","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2026.124578_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-230313","article-title":"An alternative view of familial Alzheimer\u2019s disease genetics","volume":"96","author":"Lardelli","year":"2023","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.lfs.2026.124578_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","article-title":"Gene-environment interactions in Alzheimer\u2019s disease: a potential path to precision medicine","volume":"199","author":"Eid","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2026.124578_bb0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.lfs.2026.124578_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells14040276","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2026.124578_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30112353","article-title":"Regulation of blood\u2013brain barrier permeability via JNK signaling pathway: mechanisms and potential therapeutic strategies for ischemic stroke, Alzheimer\u2019s disease and brain tumors","volume":"30","author":"Plotnikov","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2026.124578_bb0050","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/med.21719","article-title":"A multitude of signaling pathways associated with Alzheimer\u2019s disease and their roles in AD pathogenesis and therapy","volume":"41","author":"Gadhave","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2026.124578_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.lfs.2026.124578_bb0060","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-023-01848-y","article-title":"Apoptosis in Alzheimer\u2019s disease: insight into the signaling pathways and therapeutic avenues","volume":"28","author":"Kumari","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2026.124578_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00337","article-title":"Friend, foe or both? Immune activity in Alzheimer\u2019s disease","volume":"11","author":"Frost","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0070","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2023-0357","article-title":"Molecular mechanisms of cell death by parthanatos: more questions than answers","volume":"47","author":"de Moura","year":"2024","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124578_bb0075","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/febs.15716","article-title":"The role of PARP1 in neurodegenerative diseases and aging","volume":"289","author":"Mao","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2026.124578_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102651","article-title":"PARP-1 and its associated nucleases in DNA damage response","volume":"81","author":"Wang","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.lfs.2026.124578_bb0085","article-title":"The PARP enzyme family and the hallmarks of cancer part 1. Cell intrinsic hallmarks","volume":"13","author":"Dem\u00e9ny","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124578_bb0090","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/nar\/gkab020","article-title":"Dynamics of the HD regulatory subdomain of PARP-1; substrate access and allostery in PARP activation and inhibition","volume":"49","author":"Ogden","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2023.103593","article-title":"Regulatory apoptotic fragment of PARP1 complements catalytic fragment for PAR and DNA-dependent activity but inhibits DNA-induced catalytic stimulation of PARP2","volume":"133","author":"Deeksha","year":"2024","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.lfs.2026.124578_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/folmed-2017-0067","article-title":"A review on DNA repair inhibition by PARP inhibitors in cancer therapy","volume":"60","author":"Shah","year":"2018","journal-title":"Folia Med. (Plovdiv)."},{"key":"10.1016\/j.lfs.2026.124578_bb0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbrc.2020.04.120","article-title":"PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains","volume":"527","author":"Pourfarjam","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124578_bb0110","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s12276-022-00894-x","article-title":"Mitochondrial PARP1 regulates NAD+-dependent poly ADP-ribosylation of mitochondrial nucleoids","volume":"54","author":"Lee","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2026.124578_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3121\/cmr.2021.1607","article-title":"Immunohistochemical evaluation of PARP and caspase-3 as prognostic markers in prostate carcinomas","volume":"19","author":"Acar","year":"2021","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0120","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/JIR.S300679","article-title":"PARP inhibitors: an innovative approach to the treatment of inflammation and metabolic disorders in sepsis","volume":"14","author":"Wasyluk","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2025.103873","article-title":"Multiple functions of PARP1 in the repair of DNA double strand breaks","volume":"152","author":"Ortega","year":"2025","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.lfs.2026.124578_bb0130","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2026.124578_bb0135","article-title":"Molecular mechanisms of parthanatos and its role in diverse diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031499","article-title":"Genes and longevity of lifespan","volume":"23","author":"Bin-Jumah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0145","first-page":"1","article-title":"Roles of NAD+, PARP-1, and sirtuins in cell death, ischemic brain injury, and synchrotron radiation X-ray-induced tissue injury","author":"Ying","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.lfs.2026.124578_bb0150","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/3297","article-title":"Parthanatos, a messenger of death","author":"David","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0155","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1073\/pnas.0511154103","article-title":"Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology","volume":"103","author":"Yu","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0160","series-title":"Acute Neuronal Injury","first-page":"3","article-title":"Excitotoxic programmed cell death involves caspase-independent mechanisms","author":"Dawson","year":"2018"},{"key":"10.1016\/j.lfs.2026.124578_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030687","article-title":"Existing evidence for the repurposing of PARP-1 inhibitors in rare demyelinating diseases","volume":"14","author":"Mekhaeil","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124578_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.15464","article-title":"Emerging role of PARP-1 and PARthanatos in ischemic stroke","volume":"160","author":"Liu","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124578_bb0175","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s11064-012-0895-x","article-title":"Activation of PARP by oxidative stress induced by \u03b2-amyloid: implications for Alzheimer\u2019s disease","volume":"37","author":"Abeti","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072169","article-title":"PARP-1 modulates amyloid beta peptide-induced neuronal damage","volume":"8","author":"Martire","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124578_bb0185","series-title":"Poly(ADP-ribose) Polymerase 1 Deficiency Attenuates Amyloid Pathology, Neurodegeneration, and Cognitive Decline in a Familial Alzheimer\u2019s Disease Model","author":"Jhaldiyal","year":"2025"},{"key":"10.1016\/j.lfs.2026.124578_bb0190","article-title":"Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science (1979)"},{"key":"10.1016\/j.lfs.2026.124578_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105077","article-title":"PARP-1 activation leads to cytosolic accumulation of TDP-43 in neurons","volume":"148","author":"Marcus","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2026.124578_bb0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10715762.2013.857018","article-title":"Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in A\u03b2(1\u201342)-induced rat model of Alzheimer\u2019s disease","volume":"48","author":"Turunc Bayrakdar","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2017.03.027","article-title":"Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease","volume":"647","author":"Yao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2026.124578_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00310","article-title":"PARP-1 and p53 regulate the increased susceptibility to oxidative death of lymphocytes from MCI and AD patients","volume":"9","author":"Salech","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8987928","article-title":"Nucleolar PARP-1 expression is decreased in Alzheimer\u2019s disease: consequences for epigenetic regulation of rDNA and cognition","volume":"2016","author":"Zeng","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.lfs.2026.124578_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4383258","article-title":"Evidence for decreased nucleolar PARP-1 as an early marker of cognitive impairment","volume":"2019","author":"Regier","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.lfs.2026.124578_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11011-023-01330-3","article-title":"Proteomics revealed an association between ribosome-associated proteins and amyloid beta deposition in Alzheimer\u2019s disease","volume":"39","author":"Feng","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.lfs.2026.124578_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01208-4","article-title":"Altered ribosomal function and protein synthesis caused by tau","volume":"9","author":"Evans","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2026.124578_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-15-73","article-title":"The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"15","author":"Yu","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00109-022-02272-6","article-title":"Therapeutic modulation of JAK-STAT, mTOR, and PPAR-\u03b3 signaling in neurological dysfunctions","volume":"101","author":"Kumar","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.lfs.2026.124578_bb0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ibneur.2023.02.005","article-title":"Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer\u2019s disease","volume":"14","author":"Chernyuk","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.lfs.2026.124578_bb0250","article-title":"IONPs-induced neurotoxicity via cascade of neuro-oxidative stress, parthanatos-mediated cell death, neuro-inflammation and neurodegenerative changes: ameliorating effect of rosemary methanolic extract","volume":"14","author":"Elsheikh","year":"2025","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.lfs.2026.124578_bb0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neurobiolaging.2006.01.003","article-title":"Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer\u2019s disease","volume":"28","author":"Reix","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.lfs.2026.124578_bb0260","article-title":"Synaptic vesicle protein 2a mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2026.124578_bb0265","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2019.12.115","article-title":"Knockdown of macrophage migration inhibitory factor (MIF), a novel target to protect neurons from parthanatos induced by simulated post-spinal cord injury oxidative stress","volume":"523","author":"Yang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124578_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1083818","article-title":"The relevance of serum macrophage migratory inhibitory factor and cognitive dysfunction in patients with cerebral small vascular disease","volume":"15","author":"Zhao","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2119\/molmed.2009.00123","article-title":"The role of macrophage migration inhibitory factor in Alzheimer\u2019s disease","volume":"16","author":"Bacher","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2026.124578_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2025.100237","article-title":"Plasma macrophage migration inhibitory factor and matrix metalloproteinase-9 levels, and their related factors in Alzheimer\u2019s disease","volume":"18","author":"Fu","year":"2025","journal-title":"Brain Disord."},{"key":"10.1016\/j.lfs.2026.124578_bb0285","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1021\/acs.jmedchem.3c00397","article-title":"Allosteric inhibitors of macrophage migration inhibitory factor (MIF) interfere with apoptosis-inducing factor (AIF) co-localization to prevent parthanatos","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2026.124578_bb0290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12035-020-02109-8","article-title":"DNA double-strand break accumulation in Alzheimer\u2019s disease: evidence from experimental models and postmortem human brains","volume":"58","author":"Thadathil","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124578_bb0295","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1718819115","article-title":"NAD + supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124578_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157328","article-title":"Are hippocampal hypoperfusion and ATP depletion prime movers in the genesis of Alzheimer\u2019s disease? A review of recent pertinent observations from molecular biology","volume":"26","author":"Walker","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0305","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124578_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082767","article-title":"Mitochondrial protection by PARP inhibition","volume":"21","author":"Gallyas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0315","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-021-04109-w","article-title":"The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2026.124578_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081284","article-title":"Neuroprotective effects of PARP inhibitors in Drosophila models of Alzheimer\u2019s disease","volume":"11","author":"Maggiore","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2026.124578_bb0325","doi-asserted-by":"crossref","first-page":"33670","DOI":"10.1038\/s41598-025-18255-9","article-title":"Assessment of brain penetration and tumor accumulation of niraparib and olaparib: insights from multimodal imaging in preclinical models","volume":"15","author":"Groseclose","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124578_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2016.04.060","article-title":"Nicotinamide mononucleotide protects against \u03b2-amyloid oligomer-induced cognitive impairment and neuronal death","volume":"1643","author":"Wang","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0335","unstructured":"Researcher View | NCT04098666 Metformin in Alzheimer's Dementia Prevention | ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/study\/NCT04098666?tab=researcher (accessed March 15, 2026)."},{"key":"10.1016\/j.lfs.2026.124578_bb0340","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3233\/JAD-220180","article-title":"Association between metformin and Alzheimer\u2019s disease: a systematic review and meta-analysis of clinical observational studies","volume":"88","author":"Luo","year":"2022","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.lfs.2026.124578_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28166078","article-title":"Nicotinamide riboside, a promising vitamin B3 derivative for healthy aging and longevity: current research and perspectives","volume":"28","author":"Bi\u0163\u0103","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2026.124578_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/nu14020300","article-title":"Oral administration of nicotinamide mononucleotide increases nicotinamide adenine dinucleotide level in an animal brain","volume":"14","author":"Ramanathan","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2026.124578_bb0355","article-title":"PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity","volume":"9","author":"Zha","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.lfs.2026.124578_bb0360","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11523-023-00970-w","article-title":"PARP inhibitors in ovarian cancer: a review","volume":"18","author":"O\u2019Malley","year":"2023","journal-title":"Target. Oncol."},{"key":"10.1016\/j.lfs.2026.124578_bb0365","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaoncol.2023.7322","article-title":"PARP inhibitors for breast cancer treatment: a review","volume":"10","author":"Morganti","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lfs.2026.124578_bb0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-151040","article-title":"Bioenergetic impairment in animal and cellular models of Alzheimer\u2019s disease: PARP-1 inhibition rescues metabolic dysfunctions","volume":"54","author":"Martire","year":"2016","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.lfs.2026.124578_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108316","article-title":"Breast cancer therapies reduce risk of Alzheimer\u2019s disease and promote estrogenic pathways and action in brain","volume":"26","author":"Branigan","year":"2023","journal-title":"IScience"},{"key":"10.1016\/j.lfs.2026.124578_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180337","article-title":"Differences of immune disorders between Alzheimer\u2019s disease and breast cancer based on transcriptional regulation","volume":"12","author":"Kong","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124578_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108558","article-title":"Therapeutic approach for triple-negative breast Cancer through poly (ADP-ribose) Polymerase-1 inhibitors: current update","volume":"163","author":"Das","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2026.124578_bb0390","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10787-023-01255-4","article-title":"The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)","volume":"31","author":"Al-kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.lfs.2026.124578_bb0395","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","article-title":"Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Al-kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.lfs.2026.124578_bb0400","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1007\/s12035-024-04039-1","article-title":"Targeting PI3K\/Akt in cerebral ischemia reperfusion injury alleviation: from signaling networks to targeted therapy","volume":"61","author":"Zheng","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124578_bb0405","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s11064-018-2538-3","article-title":"Protective effects of notoginsenoside R1 via regulation of the PI3K-Akt-mTOR\/JNK pathway in neonatal cerebral hypoxic\u2013ischemic brain injury","volume":"43","author":"Tu","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2335","article-title":"Neuroprotective effects of metformin on cerebral ischemia-reperfusion injury by regulating PI3K\/Akt pathway","volume":"11","author":"Ruan","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.lfs.2026.124578_bb0415","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00221-021-06176-8","article-title":"Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice","volume":"239","author":"Oliveira","year":"2021","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0420","article-title":"Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110723","article-title":"Metformin alleviates cerebral ischemia\/reperfusion injury aggravated by hyperglycemia via regulating AMPK\/ULK1\/PINK1\/Parkin pathway-mediated mitophagy and apoptosis","volume":"384","author":"Guo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2026.124578_bb0430","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/1541-7786.MCR-10-0343","article-title":"Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells","volume":"9","author":"Zhuang","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151845","article-title":"Cardiovascular protective effect of metformin and telmisartan: reduction of PARP1 activity via the AMPK-PARP1 cascade","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124578_bb0440","unstructured":"Study Details | NCT00580931 Safety Study of Nicotinamide to Treat Alzheimer's Disease | ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/study\/NCT00580931 (accessed March 15, 2026)."},{"key":"10.1016\/j.lfs.2026.124578_bb0445","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11357-019-00101-2","article-title":"Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging","volume":"41","author":"Tarantini","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.lfs.2026.124578_bb0450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11095-014-1442-z","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-GP\/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699)","volume":"32","author":"Durmus","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2026.124578_bb0455","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40262-022-01157-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of rucaparib","volume":"61","author":"Liao","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2026.124578_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.633344","article-title":"Veliparib is an effective radiosensitizing agent in a preclinical model of medulloblastoma","volume":"8","author":"Buck","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.lfs.2026.124578_bb0465","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/jm801171j","article-title":"Discovery of the poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer","volume":"52","author":"Penning","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2026.124578_bb0470","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/jcph.2061","article-title":"Exposure-response model with time-varying predictors to estimate the effects of veliparib in combination with carboplatin\/paclitaxel and as monotherapy: veliparib phase 3 study in BRCA-mutated advanced breast cancer (BROCADE3) trial","volume":"62","author":"Stodtmann","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124578_bb0475","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/BCJ20230406","article-title":"Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks","volume":"481","author":"Velagapudi","year":"2024","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2026.124578_bb0480","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1016\/j.apsb.2025.09.021","article-title":"Discovery of novel radioligand [18F]AZD9574 for selective imaging of PARP1 in the CNS","volume":"15","author":"Zhou","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2026.124578_bb0485","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsmedchemlett.4c00395","article-title":"Discovery of PARP1-sparing inhibitors for protein ADP-ribosylation","volume":"15","author":"Stephens","year":"2024","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:25:58Z","timestamp":1786479958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526003875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"alternative-id":["S0024320526003875"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124578","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124578"}}